跳至主要内容
临床试验/NCT07621783
NCT07621783招募中不适用

Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context: LEADER Trial.

Imelda GI Clinical Research Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年5月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1

研究概览

简要总结

Prospectively study the correlation between Leucine-rich α2-glycoprotein (LRG) and clinical/endoscopic/histological disease activity in patients with inflammatory bowel disease (IBD) in Europe.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with confirmed diagnosis of IBD
  • Patient with planned endoscopy (ileocolonoscopy for Crohn's disease (CD)/ulcerative colitis (UC) or sigmoidoscopy for UC) for the assessment of endoscopic disease activity according to routine practice
  • willing to provide informed consent

排除标准

  • Patient with IBD unspecified
  • Patient with ileo- or colostomy
  • Patient with total colectomy
  • Women that are pregnant

研究者

发起方
Imelda GI Clinical Research Center
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验